What is CBG?
CBG stands for Cannabigerol, a minor cannabinoid found in the Cannabis sativa L. plant.
Why is it minor?
CBG has a notable effect on the endocannabinoid system as well, and has shown promise for treatment in tests with mice. CBG has demonstrated many benefits, such as reduction of inflammation, inhibition of tumor/cancer cell growth, and is known to aid in the decline of bacterial growth.
Scientists at the Molecular Neurobiology Laboratory at the University of Barcelona have developed research on cannabinoid receptors and the prospect of these receptors as, “therapeutic targets for the design and development of new drugs to treat diseases that affect the central nervous system”.
Dr. Xavier Nadal, Director of the R & D – Extraction Department at Phytoplant Research S.L. remarked: “With these findings, we demonstrate clearly that CBG is active at the cannabinoid receptors CB1 and CB2 and that it exerts its effects through those receptors. We have deepened the knowledge about phytocannabinoids and reopened the discussion about the interaction between the Cannabis plant compounds”.
Studies have concluded that CBG plays a beneficial role in the endocannabinoid system and cannabinoid receptors, both as a homeostasis regulator and as a combatant of neurodegenerative diseases.
Any further information on CBG is greatly appreciated! Share your experiences with CBG products versus CBD products, and update with any new research! thanks for your time!